Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Explainable AI Tool Identifies High-Risk Patients Before Heart Attack Reperfusion

By HospiMedica International staff writers
Posted on 14 Sep 2026

Intramyocardial hemorrhage is bleeding within the heart muscle that can occur after blood flow is restored during heart attack treatment. More...

It affects about 40% of patients treated for ST-segment elevation myocardial infarction (STEMI) and is linked to higher risks of heart failure and death. Clinicians lack a reliable way to anticipate this complication before reopening an occluded artery. Researchers have developed an explainable artificial intelligence score to flag high-risk patients before reperfusion.

State University of New York Upstate Medical University (SUNY Upstate; Syracuse, NY, USA) led the development of an intrinsically explainable AI-based scoring system to estimate the likelihood of intramyocardial hemorrhage before an artery is reopened. The approach is designed for use by interventional cardiologists in cardiac catheterization laboratories. It aims to support decision-making at the point of care for patients presenting with ST-segment elevation myocardial infarction.

The risk score is intended for application during emergency angiography to provide real-time assessment before reperfusion. It can also assist in selecting patients for closer post-procedural monitoring once flow is restored. In addition, the tool may help determine who should undergo cardiac magnetic resonance imaging and who may qualify for clinical trials focused on limiting hemorrhagic injury.

The research describing the model was published in JACC: Advances. Collaborating institutions included the Indiana University School of Medicine, the University of Toledo College of Medicine and Life Sciences, Northern Ontario School of Medicine University, Cleveland Clinic, and Upstate Medical University. The team developed and tested the score to identify patients at high risk of bleeding into damaged heart muscle after a severe heart attack using explainable artificial intelligence.

"This is the kind of AI we need for accurate, interpretable and usable data at the point of care. The SNN method allows interventionalists to see exactly which factors are driving the prediction, rather than being asked to trust a black box," said Ankur Kalra, director of cardiac catheterization laboratories and chief of cardiology at Upstate Medical University. "These findings are actionable in an electronic health record-based calculator that can help identify these patients." 

Related Links
SUNY Upstate Medical University 


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.